Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The extracellular matrix (ECM) and anchoring proteins in the dermal papilla (DP) constitute a specialized microenvironment essential for hair follicle development and cycling (Source: PubMed PMID: 10644776). The DP is a cluster of mesenchymal cells that acts as the primary signaling center, directing the proliferation and differentiation of hair matrix cells (Source: PubMed PMID: 24535019). The ECM within this niche is rich in proteoglycans like versican (Source: UniProt P13611) and structural proteins such as collagen types IV and VI, which provide both physical scaffolding and a reservoir for growth factors (Source: PubMed PMID: 15144444). These proteins facilitate the sequestration and presentation of signaling molecules like FGF-7 and BMPs to the hair follicle epithelium. In conditions like androgenetic alopecia, the DP undergoes miniaturization, characterized by a significant reduction in ECM volume and altered protein composition (Source: PubMed PMID: 11511857). Anchoring proteins and basement membrane components ensure the structural integrity of the hair bulb during the rapid expansion of the anagen phase. Therapeutic strategies often aim to restore or protect this ECM environment to maintain the DP's inductive properties and promote the transition from the telogen to the anagen phase (Source: PubMed PMID: 14996087). Drugs like minoxidil are thought to influence the DP microenvironment, potentially increasing the expression of ECM components to support hair growth (Source: PubMed PMID: 16188171).
Stimulation of extracellular matrix protein synthesis (e.g., versican, collagen) and growth factor secretion within the dermal papilla to prolong the anagen phase and reverse follicle miniaturization (Source: PubMed PMID: 14996087, 16188171).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix and anchoring proteins in dermal papilla (DP-ECM).